Home > Insider Trading > Filing (0000930413-17-003701)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
316253	Enzo Biochem Inc	ENZ	Services-Medical Laboratories (8071)	132866202

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1072922	Dov Perlysky	C/O Enzo Biochem, Inc. 527 Madison Avenue New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-31	59,455	$2.88	684,237	No	4	M	Direct
Common Stock	Disposition	2017-10-31	42,000	$9.81	642,237	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (to acquire common stock)	Disposition	2017-10-31	59,455	$2.88	59,455	$2.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
239,632	2014-01-17	2018-01-17	No	4	M	Direct

Footnotes

Represents shares sold to cover the exercise price of the Stock Options and shares sold to satisfy reporting person's tax obligations.
The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $9.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.